Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Advanced Metastatic Gastric Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 54 Carcinoma, Non-Small-Cell Lung 33 Stomach Neoplasms 27 Colorectal Neoplasms 26 Small Cell Lung Carcinoma 19 Lung Neoplasms 18 Rectal Neoplasms 16 Neoplasm Metastasis 14 Pancreatic Neoplasms 13 Neoplasms 13 Uterine Cervical Neoplasms 12 Esophageal Neoplasms 12 Nasopharyngeal Carcinoma 11 Carcinoma, Hepatocellular 11 Recurrence 10 Ovarian Neoplasms 10 Leukemia, Myeloid, Acute 10 Melanoma 9 Esophageal Squamous Cell Carcinoma 8 Colonic Neoplasms 8 Triple Negative Breast Neoplasms 7 Lymphoma, Non-Hodgkin 7 Head and Neck Neoplasms 7 Hodgkin Disease 6 Cholangiocarcinoma 6 Adenocarcinoma of Lung 6 Squamous Cell Carcinoma of Head and Neck 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms, Germ Cell and Embryonal 5 Multiple Myeloma 5

Interventions

sintilimab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04089657 2019-09-13

ASGARD

Fujian Cancer Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Metastatic Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡